Home Psoriasis Prothena Corporation plc (PRTA) Soars 13.97% on December 14

Prothena Corporation plc (PRTA) Soars 13.97% on December 14


Prothena Corporation plc (PRTA) had a good day on the market for Monday December 14
shares jumped 13.97% to close at $12.73. About 474,003 shares traded hands on 4,322 trades for the day, compared with an average daily volume of
n/a shares out of a total float of 39.92 million. After opening the trading day at $11.32, shares of Prothena Corporation plc stayed within a range of $12.87 to

With today’s gains, Prothena Corporation plc now has a market cap of
$508.2 million. Shares of Prothena Corporation plc have been trading within a range of $17.63
and $7.10 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Prothena Corp PLC is a biotechnology company focuses on the discovery, development, and commercialization of novel protein immunotherapies for the treatment of diseases that involve protein misfolding and inflammatory cell adhesion disorders. The company’s clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson’s disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Prothena Corporation plc is based out of Dublin, and has some 51 employees. Its CEO is Gene G. Kinney.

For a complete fundamental analysis of Prothena Corporation plc, check out Equities.com’s Stock Valuation Analysis report for

Still paying commissions on stock trades? Equities.com now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by https://www.equities.com/trading-start

Prothena Corporation plc is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell
Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an
objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives
a broad, unbiased look at the small-cap market as a whole.

To get more information on Prothena Corporation plc and to follow the company’s latest updates, you can visit the company’s profile page here:
PRTA’s Profile
. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s
. Also, don’t forget to sign-up for our daily
email newsletter
to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


This site uses Akismet to reduce spam. Learn how your comment data is processed.